Junya Fujimoto

52.9k total citations · 2 hit papers
122 papers, 5.1k citations indexed

About

Junya Fujimoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Junya Fujimoto has authored 122 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 43 papers in Oncology and 42 papers in Molecular Biology. Recurrent topics in Junya Fujimoto's work include Lung Cancer Treatments and Mutations (30 papers), RNA modifications and cancer (23 papers) and Cancer Genomics and Diagnostics (20 papers). Junya Fujimoto is often cited by papers focused on Lung Cancer Treatments and Mutations (30 papers), RNA modifications and cancer (23 papers) and Cancer Genomics and Diagnostics (20 papers). Junya Fujimoto collaborates with scholars based in United States, Japan and China. Junya Fujimoto's co-authors include Ignacio I. Wistuba, John D. Minna, Humam Kadara, César A. Moran, Wataru Yasui, Yang Xie, Neda Kalhor, Lauren A. Byers, Carmen Behrens and John V. Heymach and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Junya Fujimoto

115 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

2019 616 citations Triparna Sen, B. Leticia Rodriguez et al. Cancer Discovery profile →
A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer

2017 576 citations Junya Fujimoto, Ignacio I. Wistuba et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junya Fujimoto United States	34	2.5k	1.9k	1.6k	1.0k	722	122	5.1k
Surasak Phuphanich United States	34	1.7k 0.7×	1.4k 0.7×	1.3k 0.8×	822 0.8×	946 1.3×	105	5.4k
Cyrus V. Hedvat United States	35	1.7k 0.7×	2.6k 1.4×	597 0.4×	1.2k 1.1×	861 1.2×	76	5.4k
Martina Mirlacher Switzerland	39	2.5k 1.0×	2.2k 1.1×	1.6k 1.0×	1.1k 1.1×	560 0.8×	62	5.3k
Kelli Montgomery United States	43	2.1k 0.9×	3.3k 1.7×	2.4k 1.5×	1.6k 1.5×	660 0.9×	64	7.6k
Rajmohan Murali United States	51	4.3k 1.7×	3.1k 1.6×	2.2k 1.4×	1.6k 1.5×	1.2k 1.7×	179	8.5k
Alexander Quaas Germany	36	2.1k 0.8×	1.1k 0.6×	1.2k 0.7×	628 0.6×	834 1.2×	227	4.8k
Yidong Chen United States	37	1.6k 0.6×	4.3k 2.2×	1.4k 0.9×	1.7k 1.7×	698 1.0×	83	7.3k
Zhiyong Liang China	35	1.6k 0.6×	1.3k 0.7×	877 0.6×	1.1k 1.0×	344 0.5×	290	4.1k
Xing Fan China	36	1.6k 0.7×	2.6k 1.3×	662 0.4×	1.2k 1.2×	669 0.9×	188	6.1k
Thomas Hielscher Germany	39	1.6k 0.6×	3.3k 1.7×	570 0.4×	1.1k 1.1×	359 0.5×	181	5.9k

Countries citing papers authored by Junya Fujimoto

Since Specialization

Citations

This map shows the geographic impact of Junya Fujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junya Fujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junya Fujimoto more than expected).

Fields of papers citing papers by Junya Fujimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junya Fujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junya Fujimoto. The network helps show where Junya Fujimoto may publish in the future.

Co-authorship network of co-authors of Junya Fujimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Junya Fujimoto. A scholar is included among the top collaborators of Junya Fujimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junya Fujimoto. Junya Fujimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tai, Mei-Chee, Leonidas E. Bantis, Ichidai Tanaka, et al.. (2024). Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma. International Journal of Molecular Sciences. 25(4). 2331–2331.

Finnicum, Casey T., Zahraa Rahal, Maya Hassane, et al.. (2022). Pathogenesis of Tobacco-Associated Lung Adenocarcinoma Is Closely Coupled with Changes in the Gut and Lung Microbiomes. International Journal of Molecular Sciences. 23(18). 10930–10930. 7 indexed citations

Byers, Lauren A., Dmitry Bentsion, Steven Gans, et al.. (2021). Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study. Clinical Cancer Research. 27(14). 3884–3895. 52 indexed citations

Sen, Triparna, B. Leticia Rodriguez, Limo Chen, et al.. (2019). Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer. Cancer Discovery. 9(5). 646–661. 616 indexed citations breakdown →

Kantrowitz, Jacob, Ansam Sinjab, Xu Li, et al.. (2018). Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma. Cancer Prevention Research. 11(4). 237–248. 15 indexed citations

Komaki, Ritsuko, Jeremy J. Erasmus, Junya Fujimoto, Reza J. Mehran, & James D. Cox. (2018). Definition and Management of Superior Sulcus Tumors. 1(2). 37–57. 2 indexed citations

Wang, Yifan, Jayanthi Gudikote, Uma Giri, et al.. (2017). RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non–small Cell Lung Cancer. Clinical Cancer Research. 24(2). 341–350. 32 indexed citations

Miller, A. Dusty, M. De las Heras, Jingyou Yu, et al.. (2017). Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer. Retrovirology. 14(1). 3–3. 6 indexed citations

Tsao, Anne S., Heather Lin, Brett W. Carter, et al.. (2017). Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 13(2). 246–257. 9 indexed citations

10.

Kabbout, Mohamed, Melinda Garcia, Junya Fujimoto, et al.. (2013). ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(13). 3383–3395. 116 indexed citations

11.

Wistuba, Ignacio I., Carmen Behrens, Francesca Lombardi, et al.. (2013). Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma. Clinical Cancer Research. 19(22). 6261–6271. 84 indexed citations

12.

Kadara, Humam, Li Shen, Junya Fujimoto, et al.. (2012). Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling. Cancer Prevention Research. 6(1). 8–17. 26 indexed citations

13.

Tang, Ximing, Humam Kadara, Carmen Behrens, et al.. (2011). Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis. Clinical Cancer Research. 17(8). 2434–2443. 59 indexed citations

14.

Sasaki, Jun, et al.. (2011). Modeling and Control Systems Design for Air Intake System of Diesel Engines for Improvement of Transient Characteristic. Transactions of the Society of Instrument and Control Engineers. 47(9). 404–411. 1 indexed citations

15.

Chen, Yulong, Jiong Deng, Junya Fujimoto, et al.. (2010). Gprc5a Deletion Enhances the Transformed Phenotype in Normal and Malignant Lung Epithelial Cells by Eliciting Persistent Stat3 Signaling Induced by Autocrine Leukemia Inhibitory Factor. Cancer Research. 70(21). 8917–8926. 44 indexed citations

16.

Deng, Jiong, Junya Fujimoto, Carolyn S. Van Pelt, et al.. (2010). Knockout of the Tumor Suppressor Gene Gprc5a in Mice Leads to NF-κB Activation in Airway Epithelium and Promotes Lung Inflammation and Tumorigenesis. Cancer Prevention Research. 3(4). 424–437. 65 indexed citations

17.

Fujimoto, Junya, et al.. (2010). 2A1-E17 Gripper Extended Multisensory Hand Manipulating Various Types of Dishes. The Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec). 2010(0). _2A1–E17_1. 1 indexed citations

18.

Fujimoto, Junya, et al.. (2008). THE USEFULNESS OF 3D-CT FOR PANCREATIC HEAD CANCER ASSOCIATED WITH CELIAC AND SUPERIOR MESENTERIC ARTERY OCCLUSION. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(2). 448–451. 4 indexed citations

19.

Fujimoto, Junya, et al.. (2008). A CASE OF UTERINE METASTASIS FROM BREAST CANCER DETECTED BY INSTRUMENTAL FDG-PET/CT. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(8). 1887–1891. 1 indexed citations

20.

Fujimoto, Junya. (1997). Expression of E-cadherin and α- and β-catenin mRNAs in ovarian cancers. Cancer Letters. 115(2). 207–212. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact